Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Lab Invest. 2014 Jul 28;94(10):1161–1172. doi: 10.1038/labinvest.2014.103

Figure 5.

Figure 5

Human cortical synaptosome preparation labeled with the 6E10 (a–c) and the Aβ-42 (d–f) antibody against amyloid β. (a and d) Subjects were divided into 3 groups according to the Braak and Braak staging of AD: “None-II” (n = 14), “III–IV”, (n = 3),“V–VI” (n = 7). (b and e) Subjects were divided into 3 groups according to the CERAD score: “0” (n = 5), “1–2” (n = 5), and “3” (n = 14). (c and f) Subjects were divided into 3 groups according to the Thal phase: “1–2” (n = 6), “3” (n = 8) and “4–5” (n = 10). All data are presented as mean ± SEM. * p < 0.05, ** p < 0.01. Significant pairwise comparisons of groups are indicated by brackets.